Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108350 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2024-01-30 | 2024-03-17 | 217829 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2018-11-29 | 2019-06-11 | 67925 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-28 | 2019-09-03 | 87956 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90464 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2021-12-08 | 2023-06-09 | 150725 |
| PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2023-08-10 | 2023-08-28 | 201548 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2017-09-07 | 2017-10-11 | 21551 |
| PMS-IRBESARTAN | 150MG | TABLET | Resolved | 2017-10-27 | 2017-11-17 | 27343 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
| MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |
| MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |